Neuroscience Reimagined: What’s Fueling the Next Wave of Innovation and Investment?

As breakthroughs in neuroscience collide with advances in AI, precision biology, and translational medicine, the field stands on the brink of a transformative new era. Neuroscience Reimagined brings together visionary scientists, investors, and industry leaders to explore the forces reshaping discovery, development, and investment across CNS therapeutics. From decoding biological complexity and validating mechanisms with greater confidence to harnessing biomarker-driven insights and next-generation delivery technologies, the panel will examine how innovation is redefining what’s possible.

The discussion will spotlight the rise of humanised drug discovery platforms, the growing influence of rare variant research and patient advocacy, and the opportunities - and tensions - created by AI/ML-enabled R&D. Panelists will also explore the accelerating convergence between neuroscience, neuro-inflammatory disease, and metabolic disorders, revealing how cross-disciplinary science is unlocking entirely new therapeutic pathways.

This is a conversation about the future of neuroscience -…